Berenberg has initiated coverage of BioNTech (BNTX) and Moderna (MRNA), citing their leadership positions in mRNA medicine.

Berenberg analyst Harry Gillis initiated coverage of Moderna (MRNA) with a Hold rating and $42 price target. The firm says mRNA will ...

Turin Art week may be focused around Artissima, Italy’s oldest art fair, but there's must-see exhibitions to found across the ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers are broadly ...

Lidia Fonseca, CIO of Pfizer, heads data solutions and products across Pfizer and spearheads digitizing processes such as drug discovery and clinical development. She also works to streamline digital ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

Key Takeaways The S&P 500 added 0.4% on Tuesday, Nov. 19, as investors digested a strong report from a major retailer and ...

Shares are trading lower in Europe after gaining in Asia after U.S. stocks recovered somewhat from last week's swoon. Oil ...

Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...

Enoteca Monza Pizzeria Moderna, a traditional Italian restaurant concept which is part of the Foodtastic group, will be ...

A deadly outbreak of diphtheria in Khyber-Pakhtunkhwa (K-P) province has claimed the lives of 26 children, with provincial ...